연구성과로 돌아가기
2022 연구성과별 연구자 정보 (1429 / 2879)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B | Lampertico, Pietro | Lampertico, P | 24 | Univ Milan, CRC AM & A Migliavacca Ctr Liver Dis, Dept Pathophysiol & Transplantat, Milan, Italy | J-8463-2018 | Lampertico, Pietro | pindra@empal.com;gepapath@med.uoa.gr; | |||
| Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B | Dalekos, George N. | Dalekos, GN | 25 | Gen Univ Hosp Larissa, Natl Expertise Ctr Greece Autoimmune Liver Dis, Dept Med, Larisa, Greece | pindra@empal.com;gepapath@med.uoa.gr; | |||||
| Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B | Dalekos, George N. | Dalekos, GN | 25 | Gen Univ Hosp Larissa, Natl Expertise Ctr Greece Autoimmune Liver Dis, Res Lab Internal Med, Larisa, Greece | pindra@empal.com;gepapath@med.uoa.gr; | |||||
| Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B | Idilman, Ramazan | Idilman, R | 26 | Ankara Univ, Dept Gastroenterol, Sch Med, Ankara, Turkey | AFL-0461-2022 | Idilman, Ramazan | pindra@empal.com;gepapath@med.uoa.gr; | |||
| Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B | Sypsa, Vana | Sypsa, V | 27 | Natl & Kapodistrian Univ Athens, Dept Hyg Epidemiol & Med Stat, Med Sch, Athens, Greece | A-5082-2008 | SYPSA, VANA | pindra@empal.com;gepapath@med.uoa.gr; | |||
| Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B | Berg, Thomas | Berg, T | 28 | Univ Leipzig, Dept Med 2, Div Hepatol, Med Ctr, Leipzig, Germany | pindra@empal.com;gepapath@med.uoa.gr; | |||||
| Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B | Buti, Maria | Buti, M | 29 | Hosp Gen Univ Vall Hebron, Barcelona, Spain | A-5327-2019 | Buti, MARIA | pindra@empal.com;gepapath@med.uoa.gr; | |||
| Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B | Buti, Maria | Buti, M | 29 | Ciberehd, Barcelona, Spain | A-5327-2019 | Buti, MARIA | pindra@empal.com;gepapath@med.uoa.gr; | |||
| Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B | Calleja, Jose Luis | Calleja, JL | 30 | Hosp U Puerta de Hierro, IDIPHIM CIBERehd, Madrid, Spain | A-5351-2010 | Panero, Jose | pindra@empal.com;gepapath@med.uoa.gr; | |||
| Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B | Goulis, John | Goulis, J | 31 | Ristotle Univ Thessaloniki, Gen Hosp Thessaloniki Hippokratio, Dept Internal Med, Med Sch, Thessaloniki, Greece | pindra@empal.com;gepapath@med.uoa.gr; | |||||
| Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B | Manolakopoulos, Spilios | Manolakopoulos, S | 32 | Natl & Kapodistrian Univ Athens, Gen Hosp Athens Hippokratio, Dept Internal Med 2, Med Sch, Athens, Greece | AAD-7058-2019 | Manolakopoulos, Spilios | pindra@empal.com;gepapath@med.uoa.gr; | |||
| Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B | La Janssen, Harry | La Janssen, H | 33 | Univ Hlth Network, Toronto Western & Gen Hosp, Liver Clin, Toronto, ON, Canada | 0000-0003-2398-8392 | Janssen, Harry | pindra@empal.com;gepapath@med.uoa.gr; | |||
| Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B | Papatheodoridis, George, V | Papatheodoridis, G | 34 | 교신저자 | Natl & Kapodistrian Univ Athens, Gen Hosp Athens Laiko, Dept Gastroenterol, Med Sch, Athens, Greece | A-4603-2008 | Papatheodoridis, George | pindra@empal.com;gepapath@med.uoa.gr; | ||
| Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B | Lee, Jeong-Hoon | Lee, JH | 35 | 교신저자 | Seoul Natl Univ Hosp, Med Res Collaborat Ctr, Seoul, South Korea | Q-1055-2018 | Lee, Jeong-Hoon | 0000-0002-0315-2080 | Lee, Jeong-Hoon | pindra@empal.com;gepapath@med.uoa.gr; |
| Impact of intravascular ultrasound and final kissing balloon dilatation on long-term clinical outcome in percutaneous revascularization with 1-stent strategy for left main coronary artery stenosis in drug-eluting stent era | Yoon, Jae Yong | Yoon, JY | 1 | CHA Univ, CHA Gumi Med Ctr, Dept Internal Med, Gumi, South Korea | ljhmh75@knu.ac.kr; |
페이지 이동: